Titelia

Holdings of Virtus Investment Advisers, LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
415 in 11 countries
Top ten
7.7 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
201CAPITAL SOUTHWEST CORP 22,464496.9K $
202First Trust Senior Floating Rate Income Fund II 51,545496.9K $
203BlackRock Debt Strategies Fund 51,502493.9K $
204EATON VANCE SENIOR INCOME TRUST 98,865493.3K $
205GLADSTONE CAPITAL CORP 28,409492.9K $
206EATON VANCE MUNICIPAL INCOME TRUST 45,894492.4K $
207SIXTH STREET SPECIALTY LENDING INC 26,629489.4K $
208Ultragenyx Pharmaceutical Inc 23,302488.2K $
209MSC INCOME FUND INC 39,921486.2K $
210Corvus Pharmaceuticals Inc 32,579476.6K $
211FS CREDIT OPPORTUNITIES CORP 91,877468.6K $
212Rezolute Inc 151,492462.1K $
213TYRA BIOSCIENCES INC 12,049461.5K $
214Barings BDC Inc 55,991460.8K $
215CG ONCOLOGY INC 6,660450.7K $
216SLR INVESTMENT CORP 31,335448.4K $
217WHITEHORSE FINANCE INC 60,566448.2K $
218ORUKA THERAPEUTICS INC 9,034443.1K $
219Allogene Therapeutics Inc 180,588440.6K $
220Kodiak Sciences Inc 11,451436.5K $
221ARCELLX INC 3,794435.6K $
222ARES CAPITAL CORP 23,885430.4K $
223Nuvation Bio Inc 100,151429.6K $
224Tectonic Therapeutic Inc 13,799426.5K $
225LENZ Therapeutics Inc 46,542425.9K $
226ARES DYNAMIC CREDIT ALLOCATION FUND INC 34,335417.5K $
227BLACKSTONE SENIOR FLOATING RATE 2027 TERM FUND 31,759411.3K $
228Spyre Therapeutics Inc 8,110409.1K $
229Centessa Pharmaceuticals PLC 10,286408.6K $
230BLACKROCK INCOME TRUST INC 38,229404.1K $
231MORGAN STANLEY DIRECT LENDING FUND 28,292395K $
232Blackstone Strategic Credit 2027 Term Fund 35,175392.2K $
233BLACKROCK LTD DURATION INCOME TRUST 30,934389.5K $
234Intellia Therapeutics Inc 30,230387.5K $
235ADMA Biologics Inc 42,683384.6K $
236OXFORD SQUARE CAPITAL CORP 213,488377.9K $
237ORIC Pharmaceuticals Inc 29,069368.3K $
238Vir Biotechnology Inc 40,759365.2K $
239Edgewise Therapeutics Inc 11,544363.6K $
240NUVEEN CHURCHILL DIRECT LENDING CORP 28,562363.3K $
241Nektar Therapeutics 4,984358.6K $
242VAXCYTE INC 6,126356K $
243PALVELLA THERAPEUTICS INC 2,765344.7K $
244TRIPLEPOINT VENTURE GROWTH BDC CORP 68,513341.9K $
245Relay Therapeutics Inc 33,957337.9K $
246AnaptysBio Inc 6,067336.5K $
247REVOLUTION MEDICINES INC 3,454335.9K $
248OFS CAPITAL CORP 92,665329K $
249Praxis Precision Medicines Inc 1,013326.4K $
250Cullinan Therapeutics Inc 22,875325.1K $
251Terns Pharmaceuticals Inc 6,058319.4K $
252Capricor Therapeutics Inc 10,479318.6K $
253Celldex Therapeutics Inc 9,911314.4K $
254Liquidia Corp 8,169308.3K $
255BELITE BIO INC 1,929307.6K $
256CYTOMX THERAPEUTICS INC 65,080305.9K $
257Immunome Inc 13,932304.7K $
258Annexon Inc 54,866304K $
259Protagonist Therapeutics Inc 2,860301.4K $
260Apogee Therapeutics Inc 3,538297.8K $
261Celcuity Inc 2,589295.5K $
262Summit Therapeutics Inc 15,519294.2K $
263Bicara Therapeutics Inc 14,755293.5K $
264Denali Therapeutics Inc 15,166291.2K $
265AMYLYX PHARMACEUTICALS INC 20,815289.3K $
266Rocket Pharmaceuticals Inc 80,438288K $
267Precigen Inc 73,899286K $
268Scholar Rock Holding Corp 5,816285.9K $
269MAIN STREET CAPITAL CORP 5,380284.9K $
270OMEROS CORP 26,865283.7K $
271CYTOKINETICS INC 4,303283.6K $
272Rapport Therapeutics Inc 9,007281.8K $
273Compass Therapeutics Inc 52,846279.6K $
274Monte Rosa Therapeutics Inc 16,718275K $
275Stoke Therapeutics Inc 8,418274.1K $
276ARCUS BIOSCIENCES INC 12,664273.5K $
277MBX BIOSCIENCES INC 9,131272.6K $
278Zymeworks Inc 10,702268K $
279Ironwood Pharmaceuticals Inc 76,169267.4K $
280Ideaya Biosciences Inc 8,014267K $
281Nuvalent Inc 2,602266.6K $
282Neurogene Inc 13,033262.7K $
283Septerna Inc 10,719257.6K $
284ArriVent Biopharma Inc 11,165257.6K $
285DYNE THERAPEUTICS INC 14,150256.5K $
286IMMUNOVANT INC 10,320256.3K $
287JADE BIOSCIENCES INC 18,203255.8K $
288Sionna Therapeutics Inc 6,374255.5K $
289KYMERA THERAPEUTICS INC 3,040253.2K $
290COGENT BIOSCIENCES INC 6,476249.3K $
291Janux Therapeutics Inc 17,821247.7K $
292BCP INVESTMENT CORP 32,830246.9K $
293Viking Therapeutics Inc 7,354239.3K $
294Beam Therapeutics Inc 9,966237.5K $
2954D Molecular Therapeutics Inc 25,154234.2K $
296PRIME MEDICINE INC 66,508231.4K $
297Inhibrx Biosciences Inc 3,425230.3K $
298Arvinas Inc 21,676229.8K $
299AtaiBeckley Inc 63,563225K $
300COMPASS PATHWAYS PLC 40,457223.7K $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Financials 12.5 %
  • Industrials 11.4 %
  • Health care 9.9 %
  • Technology 9.9 %
  • Consumer discretionary 5.2 %
  • Consumer staples 2.9 %
  • Materials 2.6 %
  • Communication 1.6 %
  • Utilities 1.2 %
  • Real estate 0.8 %
  • Energy 0.4 %
  • Unattributed 41.6 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 97.8 %
  • Cayman Islands 0.6 %
  • Uruguay 0.4 %
  • United Kingdom 0.4 %
  • Denmark 0.3 %
  • Germany 0.2 %
  • Brazil 0.2 %
  • Luxembourg 0.1 %
  • South Korea 0.1 %
  • Chile 0.1 %
  • Türkiye 0.1 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States396328.8M $97.75 %
2Cayman Islands31.9M $0.56 %
3Uruguay11.4M $0.43 %
4United Kingdom61.2M $0.37 %
5Denmark1876K $0.26 %
6Germany1791.4K $0.24 %
7Brazil3576.2K $0.17 %
8Luxembourg1191.9K $0.06 %
9South Korea1190K $0.06 %
10Chile1185.9K $0.06 %
11Türkiye1184.9K $0.05 %
Cite this page

Titelia. "Holdings of Virtus Investment Advisers, LLC". https://titelia.com/en/funds/US13F19481